Atlas Discovery launches AI models to predict patient response in clinical trials
The startup says a retrospective ulcerative colitis analysis predicted treatment response at 0.76 AUROC and could have maintained statistical power with roughly 450 fewer patients.
By Ryan Merket · Published · Updated
Primary source: X
Why it matters
Founder posts on X can signal early interest or endorsement of external content, but without context the impact on the startup ecosystem remains unclear.
Atlas Discovery has launched out of stealth with foundation models designed to predict how individual patients will respond to drugs in clinical trials, according to an article published on X by Y Combinator general partner Ankit Gupta.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.